Status:
COMPLETED
The Diagnostic Value of Acupoint Sensitization Based on Stable Angina Pectoris
Lead Sponsor:
West China Hospital
Conditions:
Stable Angina Pectoris
Acupoint Sensitization
Eligibility:
All Genders
35-80 years
Brief Summary
Investigators adopt cross-sectional study design to carry out the exemplary research in the aspects of disease diagnosis.This study is designed to confirm the hypothesis "acupoint sensitization is ass...
Eligibility Criteria
Inclusion
- Patients meet the diagnostic criteria of ACC/AHA angina pectoris of coronary heart disease
- The frequency of angina attacks were greater or equal to twice a week over the previous 3 months
- Patients agree to do coronary angiography examination and sign the informed consent.
Exclusion
- People with mental disabilities and intelligent obstacle
- Patients who can't accomplish the detection of acupoint sensitization
- Patients with allergic condition, especially the contrast media
- Patients with acute myocardial infarction, unstable angina, during arrhythmia and serious diseases which can affect the blood supply of myocardial
- Patients with skin or peripheral nerve paresthesia, pain or the detect area of skin ulcerate
- Pregnant or lactating women
- Patients who undergoing other clinical trials
Key Trial Info
Start Date :
December 6 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 29 2018
Estimated Enrollment :
183 Patients enrolled
Trial Details
Trial ID
NCT03341663
Start Date
December 6 2017
End Date
November 29 2018
Last Update
May 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The West China Hospital of Sichuan university
Chengdu, Sichuan, China, 610041